BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
569815	O=C1NCc2cc(Nc3ncnc4[nH]cnc34)ccc12	InChI=1S/C13H10N6O/c20-13-9-2-1-8(3-7(9)4-14-13)19-12-10-11(16-5-15-10)17-6-18-12/h1-3,5-6H,4H2,(H,14,20)(H2,15,16,17,18,19)	ZVKNCTZBEXAHCH-UHFFFAOYSA-N	297336	US10112955, Example 1::5-((9H-purin-6-yl)amino)isoindolin-1-one (Cpd. No. 1F)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297336	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297336&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071500	381620192					C02860		1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569816	CN1Cc2cc(Nc3ncnc4[nH]cnc34)ccc2C1=O	InChI=1S/C14H12N6O/c1-20-5-8-4-9(2-3-10(8)14(20)21)19-13-11-12(16-6-15-11)17-7-18-13/h2-4,6-7H,5H2,1H3,(H2,15,16,17,18,19)	CUXKGEHMNBXMDK-UHFFFAOYSA-N	297337	US10112955, Example 2::5-((9H-purin-6-yl)amino)-2-methylisoindolin-1-one (Cpd. No. 2F)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297337	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297337&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071367	381620193					C02860		1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569817	O=C1NCc2cc(Nc3ccncn3)ccc12	InChI=1S/C12H10N4O/c17-12-10-2-1-9(5-8(10)6-14-12)16-11-3-4-13-7-15-11/h1-5,7H,6H2,(H,14,17)(H,13,15,16)	FAKOYOYLAGECDB-UHFFFAOYSA-N	297338	US10112955, Example 3::5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 3F)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297338	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297338&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071410	381620194							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569818	Clc1cc(Nc2ccc3C(=O)NCc3c2)ncn1	InChI=1S/C12H9ClN4O/c13-10-4-11(16-6-15-10)17-8-1-2-9-7(3-8)5-14-12(9)18/h1-4,6H,5H2,(H,14,18)(H,15,16,17)	GGYMECBWFXALOZ-UHFFFAOYSA-N	297339	US10112955, Example 4::5-((6-chloropyrimidin-4-yl)amino)isoindolin-1-one (Cpd. No. 4F)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297339	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297339&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071573	381620195							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569819	O=C1CCc2cc(Nc3ccncn3)ccc12	InChI=1S/C13H11N3O/c17-12-4-1-9-7-10(2-3-11(9)12)16-13-5-6-14-8-15-13/h2-3,5-8H,1,4H2,(H,14,15,16)	RDGJOARXUHDTDR-UHFFFAOYSA-N	297340	US10112955, Example 5::5-(pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-1-one (Cpd. No. 5)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297340	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297340&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071503	381620196							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569820	Cn1cc(Nc2cc(Nc3ccc4C(=O)NCc4c3)ncn2)cn1	InChI=1S/C16H15N7O/c1-23-8-12(7-20-23)22-15-5-14(18-9-19-15)21-11-2-3-13-10(4-11)6-17-16(13)24/h2-5,7-9H,6H2,1H3,(H,17,24)(H2,18,19,21,22)	RGFDAUFAROCPOW-UHFFFAOYSA-N	297341	US10112955, Example 6::5-((6-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)amino)isoindolin-1-one (Cpd. No. 6F)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297341	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297341&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071511	381620197							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569821	CC1NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C13H12N4O/c1-8-11-6-9(2-3-10(11)13(18)16-8)17-12-4-5-14-7-15-12/h2-8H,1H3,(H,16,18)(H,14,15,17)	OWEDOBFUVPKBNA-UHFFFAOYSA-N	297342	US10112955, Example 8::3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 8)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297342	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297342&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071308	381620198							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569822	CC1NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C13H12N4O/c1-8-11-6-9(2-3-10(11)13(18)16-8)17-12-4-5-14-7-15-12/h2-8H,1H3,(H,16,18)(H,14,15,17)	OWEDOBFUVPKBNA-UHFFFAOYSA-N	297342	US10112955, Example 8::3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 8)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297342	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297342&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071308	381620198							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569823	O=C1NCCc2cc(Nc3ccncn3)ccc12	InChI=1S/C13H12N4O/c18-13-11-2-1-10(7-9(11)3-6-15-13)17-12-4-5-14-8-16-12/h1-2,4-5,7-8H,3,6H2,(H,15,18)(H,14,16,17)	ZEQJVQLQTLNOBZ-UHFFFAOYSA-N	297343	US10112955, Example 10::6-(pyrimidin-4-ylamino)-3,4-dihydroisoquinolin-1(2H)-one (Cpd. No. 10)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297343	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297343&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071307	381620199							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569824	O=C1NCCc2cc(Nc3ccncn3)ccc12	InChI=1S/C13H12N4O/c18-13-11-2-1-10(7-9(11)3-6-15-13)17-12-4-5-14-8-16-12/h1-2,4-5,7-8H,3,6H2,(H,15,18)(H,14,16,17)	ZEQJVQLQTLNOBZ-UHFFFAOYSA-N	297343	US10112955, Example 10::6-(pyrimidin-4-ylamino)-3,4-dihydroisoquinolin-1(2H)-one (Cpd. No. 10)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297343	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297343&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071307	381620199							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569825	CC(=O)Nc1cc(Nc2ccc3C(=O)NCc3c2)ncn1	InChI=1S/C14H13N5O2/c1-8(20)18-12-5-13(17-7-16-12)19-10-2-3-11-9(4-10)6-15-14(11)21/h2-5,7H,6H2,1H3,(H,15,21)(H2,16,17,18,19,20)	ZLLNQWSQWRHIKS-UHFFFAOYSA-N	297344	US10112955, Example 11::N-(6-((1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)acetamide (Cpd. No. 11)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297344	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297344&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071508	381620200							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569826	CC(=O)Nc1cc(Nc2ccc3C(=O)NCc3c2)ncn1	InChI=1S/C14H13N5O2/c1-8(20)18-12-5-13(17-7-16-12)19-10-2-3-11-9(4-10)6-15-14(11)21/h2-5,7H,6H2,1H3,(H,15,21)(H2,16,17,18,19,20)	ZLLNQWSQWRHIKS-UHFFFAOYSA-N	297344	US10112955, Example 11::N-(6-((1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)acetamide (Cpd. No. 11)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297344	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297344&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071508	381620200							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569827	O=C(Nc1cc(Nc2ccc3C(=O)NCc3c2)ncn1)C1CC1	InChI=1S/C16H15N5O2/c22-15(9-1-2-9)21-14-6-13(18-8-19-14)20-11-3-4-12-10(5-11)7-17-16(12)23/h3-6,8-9H,1-2,7H2,(H,17,23)(H2,18,19,20,21,22)	MIVZVCNGBMCBAA-UHFFFAOYSA-N	297345	US10112955, Example 12::N-(6-((1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 12)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297345	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297345&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071545	381620201							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569828	O=C(Nc1cc(Nc2ccc3C(=O)NCc3c2)ncn1)C1CC1	InChI=1S/C16H15N5O2/c22-15(9-1-2-9)21-14-6-13(18-8-19-14)20-11-3-4-12-10(5-11)7-17-16(12)23/h3-6,8-9H,1-2,7H2,(H,17,23)(H2,18,19,20,21,22)	MIVZVCNGBMCBAA-UHFFFAOYSA-N	297345	US10112955, Example 12::N-(6-((1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 12)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297345	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297345&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071545	381620201							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569829	CC(C)C1NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C15H16N4O/c1-9(2)14-12-7-10(3-4-11(12)15(20)19-14)18-13-5-6-16-8-17-13/h3-9,14H,1-2H3,(H,19,20)(H,16,17,18)	PLZBJLWXNDHFTE-UHFFFAOYSA-N	297346	US10112955, Example 13::3-isopropyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 13)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297346	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297346&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071644	381620202							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569830	CC(C)C1NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C15H16N4O/c1-9(2)14-12-7-10(3-4-11(12)15(20)19-14)18-13-5-6-16-8-17-13/h3-9,14H,1-2H3,(H,19,20)(H,16,17,18)	PLZBJLWXNDHFTE-UHFFFAOYSA-N	297346	US10112955, Example 13::3-isopropyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 13)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297346	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297346&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071644	381620202							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569831	CC1(C)NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-14(2)11-7-9(3-4-10(11)13(19)18-14)17-12-5-6-15-8-16-12/h3-8H,1-2H3,(H,18,19)(H,15,16,17)	PXYXJSKWHPGJFP-UHFFFAOYSA-N	297347	US10112955, Example 15::3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 15)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297347&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071521	381620203							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569832	CC1(C)NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-14(2)11-7-9(3-4-10(11)13(19)18-14)17-12-5-6-15-8-16-12/h3-8H,1-2H3,(H,18,19)(H,15,16,17)	PXYXJSKWHPGJFP-UHFFFAOYSA-N	297347	US10112955, Example 15::3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 15)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297347&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071521	381620203							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569833	CSc1cc(Nc2ccc3C(=O)NC(C)c3c2)ncn1	InChI=1S/C14H14N4OS/c1-8-11-5-9(3-4-10(11)14(19)17-8)18-12-6-13(20-2)16-7-15-12/h3-8H,1-2H3,(H,17,19)(H,15,16,18)	PHLQHWVHDQDTBN-UHFFFAOYSA-N	297348	US10112955, Example 16::3-methyl-5-((6-(methylthio)pyrimidin-4-yl)amino)isoindolin-1-one (Cpd. No. 16)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297348	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297348&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071439	381620204							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569834	CC1NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)cc12	InChI=1S/C17H17N5O2/c1-9-13-6-11(4-5-12(13)17(24)20-9)21-14-7-15(19-8-18-14)22-16(23)10-2-3-10/h4-10H,2-3H2,1H3,(H,20,24)(H2,18,19,21,22,23)	XTDVNWGYGGANTH-UHFFFAOYSA-N	297349	US10112955, Example 17::N-(6-((3-methyl-1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 17)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297349	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297349&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071638	381620205							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569835	CC1NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)cc12	InChI=1S/C17H17N5O2/c1-9-13-6-11(4-5-12(13)17(24)20-9)21-14-7-15(19-8-18-14)22-16(23)10-2-3-10/h4-10H,2-3H2,1H3,(H,20,24)(H2,18,19,21,22,23)	XTDVNWGYGGANTH-UHFFFAOYSA-N	297349	US10112955, Example 17::N-(6-((3-methyl-1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 17)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297349	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297349&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071638	381620205							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569836	CC1NC(=O)c2ccc(Nc3cc(NC(=O)C(C)(C)C)ncn3)cc12	InChI=1S/C18H21N5O2/c1-10-13-7-11(5-6-12(13)16(24)21-10)22-14-8-15(20-9-19-14)23-17(25)18(2,3)4/h5-10H,1-4H3,(H,21,24)(H2,19,20,22,23,25)	UNNPSSDQXSQHKA-UHFFFAOYSA-N	297350	US10112955, Example 18::N-(6-((3-methyl-1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)pivalamide (Cpd. No. 18)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297350	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297350&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071537	381620206							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569837	CC1CC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)cc12	InChI=1S/C18H18N4O2/c1-10-6-15(23)13-5-4-12(7-14(10)13)21-16-8-17(20-9-19-16)22-18(24)11-2-3-11/h4-5,7-11H,2-3,6H2,1H3,(H2,19,20,21,22,24)	VQQLZYYYFZKNPK-UHFFFAOYSA-N	297351	US10112955, Example 19::N-(6-((3-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 19)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297351	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297351&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071399	381620207							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569838	CC1CC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)cc12	InChI=1S/C18H18N4O2/c1-10-6-15(23)13-5-4-12(7-14(10)13)21-16-8-17(20-9-19-16)22-18(24)11-2-3-11/h4-5,7-11H,2-3,6H2,1H3,(H2,19,20,21,22,24)	VQQLZYYYFZKNPK-UHFFFAOYSA-N	297351	US10112955, Example 19::N-(6-((3-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 19)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297351	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297351&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071399	381620207							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569839	CC1N(C)C(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-9-12-7-10(17-13-5-6-15-8-16-13)3-4-11(12)14(19)18(9)2/h3-9H,1-2H3,(H,15,16,17)	NBAYXPBILXYQAX-UHFFFAOYSA-N	297352	US10112955, Example 20::2,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 20)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297352	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297352&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071328	381620208							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569840	CC1Cc2cc(Nc3ccncn3)ccc2NC1=O	InChI=1S/C14H14N4O/c1-9-6-10-7-11(2-3-12(10)18-14(9)19)17-13-4-5-15-8-16-13/h2-5,7-9H,6H2,1H3,(H,18,19)(H,15,16,17)	PWTHPTLVXMYRRD-UHFFFAOYSA-N	297353	US10112955, Example 21::3-methyl-6-(pyrimidin-4-ylamino)-3,4-dihydroquinolin-2(1H)-one (Cpd. No. 21)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297353	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297353&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071315	381620209							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569841	CC1CNC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-9-7-16-14(19)11-3-2-10(6-12(9)11)18-13-4-5-15-8-17-13/h2-6,8-9H,7H2,1H3,(H,16,19)(H,15,17,18)	WIPWOBQRZYJFLH-UHFFFAOYSA-N	297354	US10112955, Example 22::4-methyl-6-(pyrimidin-4-ylamino)-3,4-dihydroisoquinolin-1(2H)-one (Cpd. No. 22)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297354	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297354&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071655	381620210							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569842	CC1CNC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-9-7-16-14(19)11-3-2-10(6-12(9)11)18-13-4-5-15-8-17-13/h2-6,8-9H,7H2,1H3,(H,16,19)(H,15,17,18)	WIPWOBQRZYJFLH-UHFFFAOYSA-N	297354	US10112955, Example 22::4-methyl-6-(pyrimidin-4-ylamino)-3,4-dihydroisoquinolin-1(2H)-one (Cpd. No. 22)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297354	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297354&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071655	381620210							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569843	CC1Cc2cc(Nc3ccncn3)ccc2C(=O)N1	InChI=1S/C14H14N4O/c1-9-6-10-7-11(2-3-12(10)14(19)17-9)18-13-4-5-15-8-16-13/h2-5,7-9H,6H2,1H3,(H,17,19)(H,15,16,18)	DKASWHAYGWZSAG-UHFFFAOYSA-N	297355	US10112955, Example 23::3-methyl-6-(pyrimidin-4-ylamino)-3, 4-dihydroisoquinolin-1(2H)-one (Cpd. No. 23)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297355&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071398	381620211							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569844	CC1Cc2cc(Nc3ccncn3)ccc2C(=O)N1	InChI=1S/C14H14N4O/c1-9-6-10-7-11(2-3-12(10)14(19)17-9)18-13-4-5-15-8-16-13/h2-5,7-9H,6H2,1H3,(H,17,19)(H,15,16,18)	DKASWHAYGWZSAG-UHFFFAOYSA-N	297355	US10112955, Example 23::3-methyl-6-(pyrimidin-4-ylamino)-3, 4-dihydroisoquinolin-1(2H)-one (Cpd. No. 23)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297355&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071398	381620211							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569845	CC1NC(=O)c2ccc(Nc3ccnc(NC(=O)C4CC4)c3)cc12	InChI=1S/C18H18N4O2/c1-10-15-8-12(4-5-14(15)18(24)20-10)21-13-6-7-19-16(9-13)22-17(23)11-2-3-11/h4-11H,2-3H2,1H3,(H,20,24)(H2,19,21,22,23)	QAJDDCKVTPAWLY-UHFFFAOYSA-N	297356	US10112955, Example 24::N-(4-((3-methyl-1-oxoisoindolin-5-yl) amino) pyridin-2-yl) cyclopropane carboxamide (Cpd. No. 24)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297356	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297356&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071471	381620212							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569846	CC1NC(=O)c2ccc(Nc3ccnc(NC(=O)C4CC4)c3)cc12	InChI=1S/C18H18N4O2/c1-10-15-8-12(4-5-14(15)18(24)20-10)21-13-6-7-19-16(9-13)22-17(23)11-2-3-11/h4-11H,2-3H2,1H3,(H,20,24)(H2,19,21,22,23)	QAJDDCKVTPAWLY-UHFFFAOYSA-N	297356	US10112955, Example 24::N-(4-((3-methyl-1-oxoisoindolin-5-yl) amino) pyridin-2-yl) cyclopropane carboxamide (Cpd. No. 24)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297356	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297356&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071471	381620212							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569847	CNc1cc(Nc2ccc3C(=O)NC(C)c3c2)ccn1	InChI=1S/C15H16N4O/c1-9-13-7-10(3-4-12(13)15(20)18-9)19-11-5-6-17-14(8-11)16-2/h3-9H,1-2H3,(H,18,20)(H2,16,17,19)	SNCFCFMENPRQTN-UHFFFAOYSA-N	297357	US10112955, Example 25::3-methyl-5-((2-(methyl amino) pyridin-4-yl) amino) isoindolin-1-one (Cpd. No. 25)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297357	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297357&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071560	381620213							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569848	CC1NC(=O)c2ccc(NC(=O)OC(C)(C)C)cc12	InChI=1S/C14H18N2O3/c1-8-11-7-9(5-6-10(11)12(17)15-8)16-13(18)19-14(2,3)4/h5-8H,1-4H3,(H,15,17)(H,16,18)	MGLZFYNXHOKFJT-UHFFFAOYSA-N	297358	US10112955, Example 26::3-methyl-5-((6-methylpyrimidin-4-yl)amino)isoindolin-1-one (Cpd. No. 26)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297358	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297358&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			137529648	381620214							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569849	O=c1[nH]sc2cc(Nc3ccncn3)ccc12	InChI=1S/C11H8N4OS/c16-11-8-2-1-7(5-9(8)17-15-11)14-10-3-4-12-6-13-10/h1-6H,(H,15,16)(H,12,13,14)	PNYXLQCDCIDXQX-UHFFFAOYSA-N	297359	US10112955, Example 27::6-(pyrimidin-4-ylamino)benzo[d]isothiazol-3(2H)-one (Cpd. No. 27)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297359	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297359&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			137529649	381620215							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569850	NC1CC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C13H12N4O/c14-11-6-12(18)9-2-1-8(5-10(9)11)17-13-3-4-15-7-16-13/h1-5,7,11H,6,14H2,(H,15,16,17)	IDCSUWXPQSCZPM-UHFFFAOYSA-N	297360	US10112955, Example 28::3-amino-5-(pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-1-one (Cpd. No. 28)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297360	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297360&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071489	381620216							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569851	O=C1NC2CC2c2cc(Nc3ccncn3)ccc12	InChI=1S/C14H12N4O/c19-14-9-2-1-8(17-13-3-4-15-7-16-13)5-10(9)11-6-12(11)18-14/h1-5,7,11-12H,6H2,(H,18,19)(H,15,16,17)	VMQOZKDOCMTDLJ-UHFFFAOYSA-N	297361	US10112955, Example 29::6-(pyrimidin-4-ylamino)-1,1a,2,7b-tetrahydro-3H-cyclopropa[c]isoquinolin-3-one (Cpd. No. 29)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297361	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297361&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071633	381620217							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569852	CC1(N)CC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H14N4O/c1-14(15)7-12(19)10-3-2-9(6-11(10)14)18-13-4-5-16-8-17-13/h2-6,8H,7,15H2,1H3,(H,16,17,18)	UFFWLDUZEJENAV-UHFFFAOYSA-N	297362	US10112955, Example 30::3-amino-3-methyl-5-(pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-1-one (Cpd. No. 30)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297362	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297362&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071576	381620218							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569853	CC1(N)CNC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H15N5O/c1-14(15)7-17-13(20)10-3-2-9(6-11(10)14)19-12-4-5-16-8-18-12/h2-6,8H,7,15H2,1H3,(H,17,20)(H,16,18,19)	KGMGBSDRLKHOAS-UHFFFAOYSA-N	297363	US10112955, Example 32::4-amino-4-methyl-6-(pyrimidin-4-ylamino)-3,4-dihydroisoquinolin-1(2H)-one (Cpd. No. 32)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297363	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297363&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071571	381620219							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569854	CC1NC(=O)c2c1cc(Nc1ccncn1)cc2C	InChI=1S/C14H14N4O/c1-8-5-10(18-12-3-4-15-7-16-12)6-11-9(2)17-14(19)13(8)11/h3-7,9H,1-2H3,(H,17,19)(H,15,16,18)	PGCQCLPSSJBTRH-UHFFFAOYSA-N	297364	US10112955, Example 33::3,7-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 33)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297364	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297364&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071301	381620220							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569855	CC1NC(=O)c2c1cc(Nc1ccncn1)cc2C	InChI=1S/C14H14N4O/c1-8-5-10(18-12-3-4-15-7-16-12)6-11-9(2)17-14(19)13(8)11/h3-7,9H,1-2H3,(H,17,19)(H,15,16,18)	PGCQCLPSSJBTRH-UHFFFAOYSA-N	297364	US10112955, Example 33::3,7-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 33)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297364	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297364&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071301	381620220							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569856	CC1NC(=O)c2c1cc(Nc1ccncn1)cc2Cl	InChI=1S/C13H11ClN4O/c1-7-9-4-8(18-11-2-3-15-6-16-11)5-10(14)12(9)13(19)17-7/h2-7H,1H3,(H,17,19)(H,15,16,18)	DDYNEGJKWWULKJ-UHFFFAOYSA-N	297365	US10112955, Example 35::7-chloro-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 35)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297365	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297365&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071340	381620221							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569857	CC1NC(=O)c2c1cc(Nc1ccncn1)cc2Cl	InChI=1S/C13H11ClN4O/c1-7-9-4-8(18-11-2-3-15-6-16-11)5-10(14)12(9)13(19)17-7/h2-7H,1H3,(H,17,19)(H,15,16,18)	DDYNEGJKWWULKJ-UHFFFAOYSA-N	297365	US10112955, Example 35::7-chloro-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 35)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297365	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297365&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071340	381620221							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569858	CC1(C)NC(=O)c2c1cc(Nc1ccncn1)cc2Cl	InChI=1S/C14H13ClN4O/c1-14(2)9-5-8(18-11-3-4-16-7-17-11)6-10(15)12(9)13(20)19-14/h3-7H,1-2H3,(H,19,20)(H,16,17,18)	ZTNMOTNCQVCIEP-UHFFFAOYSA-N	297366	US10112955, Example 36::7-chloro-3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 36)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297366	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297366&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071538	381620222							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569859	CC1(C)NC(=O)c2c1cc(Nc1ccncn1)cc2Cl	InChI=1S/C14H13ClN4O/c1-14(2)9-5-8(18-11-3-4-16-7-17-11)6-10(15)12(9)13(20)19-14/h3-7H,1-2H3,(H,19,20)(H,16,17,18)	ZTNMOTNCQVCIEP-UHFFFAOYSA-N	297366	US10112955, Example 36::7-chloro-3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (Cpd. No. 36)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297366	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297366&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071538	381620222							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569860	O=C1NC(c2ccsc2)c2cc(Nc3ccncn3)ccc12	InChI=1S/C16H12N4OS/c21-16-12-2-1-11(19-14-3-5-17-9-18-14)7-13(12)15(20-16)10-4-6-22-8-10/h1-9,15H,(H,20,21)(H,17,18,19)	KUHYGUXTOZBOFJ-UHFFFAOYSA-N	297367	US10112955, Example 37::5-(pyrimidin-4-ylamino)-3-(thiophen-3-yl)isoindolin-1-one (Cpd. No. 37)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297367	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297367&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071444	381620223							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569861	O=C1NC(c2ccsc2)c2cc(Nc3ccncn3)ccc12	InChI=1S/C16H12N4OS/c21-16-12-2-1-11(19-14-3-5-17-9-18-14)7-13(12)15(20-16)10-4-6-22-8-10/h1-9,15H,(H,20,21)(H,17,18,19)	KUHYGUXTOZBOFJ-UHFFFAOYSA-N	297367	US10112955, Example 37::5-(pyrimidin-4-ylamino)-3-(thiophen-3-yl)isoindolin-1-one (Cpd. No. 37)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297367	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297367&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071444	381620223							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569862	CC1NC(=O)c2ccc(Nc3ncnc4NCCOc34)cc12	InChI=1S/C15H15N5O2/c1-8-11-6-9(2-3-10(11)15(21)19-8)20-14-12-13(17-7-18-14)16-4-5-22-12/h2-3,6-8H,4-5H2,1H3,(H,19,21)(H2,16,17,18,20)	FHHPXSOPICZZEF-UHFFFAOYSA-N	297368	US10112955, Example 38::5-(7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-ylamino)-3-methyl-isoindolin-1-one (Cpd. No. 38)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297368	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297368&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071351	381620224							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569863	CC1NC(=O)c2ccc(Nc3ncnc4NCCOc34)cc12	InChI=1S/C15H15N5O2/c1-8-11-6-9(2-3-10(11)15(21)19-8)20-14-12-13(17-7-18-14)16-4-5-22-12/h2-3,6-8H,4-5H2,1H3,(H,19,21)(H2,16,17,18,20)	FHHPXSOPICZZEF-UHFFFAOYSA-N	297368	US10112955, Example 38::5-(7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-ylamino)-3-methyl-isoindolin-1-one (Cpd. No. 38)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297368	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297368&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071351	381620224							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569864	CC1NC(=O)c2ccc(Nc3ncnc4NCCc34)cc12	InChI=1S/C15H15N5O/c1-8-12-6-9(2-3-10(12)15(21)19-8)20-14-11-4-5-16-13(11)17-7-18-14/h2-3,6-8H,4-5H2,1H3,(H,19,21)(H2,16,17,18,20)	GJSJXXQIAMINMU-UHFFFAOYSA-N	297369	US10112955, Example 39::5-(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-3-methyl-isoindolin-1-one (Cpd. No. 39)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 550							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297369	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297369&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071718	381620225							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569865	CC1NC(=O)c2ccc(Nc3ncnc4NCCc34)cc12	InChI=1S/C15H15N5O/c1-8-12-6-9(2-3-10(12)15(21)19-8)20-14-11-4-5-16-13(11)17-7-18-14/h2-3,6-8H,4-5H2,1H3,(H,19,21)(H2,16,17,18,20)	GJSJXXQIAMINMU-UHFFFAOYSA-N	297369	US10112955, Example 39::5-(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-3-methyl-isoindolin-1-one (Cpd. No. 39)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297369	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297369&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071718	381620225							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569866	CC1(CN)NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H15N5O/c1-14(7-15)11-6-9(2-3-10(11)13(20)19-14)18-12-4-5-16-8-17-12/h2-6,8H,7,15H2,1H3,(H,19,20)(H,16,17,18)	OXVHXHXUCPFSNI-UHFFFAOYSA-N	297370	US10112955, Example 40::3-(aminomethyl)-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one hydrochloride salt (Cpd. No. 40)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		 5050							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297370	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297370&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071551	381620226							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569867	CC1(CN)NC(=O)c2ccc(Nc3ccncn3)cc12	InChI=1S/C14H15N5O/c1-14(7-15)11-6-9(2-3-10(11)13(20)19-14)18-12-4-5-16-8-17-12/h2-6,8H,7,15H2,1H3,(H,19,20)(H,16,17,18)	OXVHXHXUCPFSNI-UHFFFAOYSA-N	297370	US10112955, Example 40::3-(aminomethyl)-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one hydrochloride salt (Cpd. No. 40)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297370	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297370&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071551	381620226							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569868	CC1NC(=O)c2ccc(Nc3ncnc4NC(=O)Cc34)cc12	InChI=1S/C15H13N5O2/c1-7-10-4-8(2-3-9(10)15(22)18-7)19-13-11-5-12(21)20-14(11)17-6-16-13/h2-4,6-7H,5H2,1H3,(H,18,22)(H2,16,17,19,20,21)	YQVSHAKGDVHEPL-UHFFFAOYSA-N	297371	US10112955, Example 41::4-[(3-methyl-1-oxo-isoindolin-5-yl)amino]-5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one (Cpd. No. 41)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 5050							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297371	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297371&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071726	381620227							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569869	CC1NC(=O)c2cnc(Nc3ccnc(NC(=O)C4CC4)c3)cc12	InChI=1S/C17H17N5O2/c1-9-12-7-15(19-8-13(12)17(24)20-9)21-11-4-5-18-14(6-11)22-16(23)10-2-3-10/h4-10H,2-3H2,1H3,(H,20,24)(H2,18,19,21,22,23)	ARZDDXOWPLLRKD-UHFFFAOYSA-N	297372	US10112955, Example 42::N-(4-((1-methyl-3-oxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-yl)amino)pyridin-2-yl)cyclopropanecarboxamide (Cpd. No. 42)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297372	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297372&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071543	381620228							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569870	CC1NC(=O)c2cnc(Nc3ccnc(NC(=O)C4CC4)c3)cc12	InChI=1S/C17H17N5O2/c1-9-12-7-15(19-8-13(12)17(24)20-9)21-11-4-5-18-14(6-11)22-16(23)10-2-3-10/h4-10H,2-3H2,1H3,(H,20,24)(H2,18,19,21,22,23)	ARZDDXOWPLLRKD-UHFFFAOYSA-N	297372	US10112955, Example 42::N-(4-((1-methyl-3-oxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-yl)amino)pyridin-2-yl)cyclopropanecarboxamide (Cpd. No. 42)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297372	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297372&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071543	381620228							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569871	CC1(C)NC(=O)c2c1cc(Nc1cc(N)ncn1)cc2Cl	InChI=1S/C14H14ClN5O/c1-14(2)8-3-7(4-9(15)12(8)13(21)20-14)19-11-5-10(16)17-6-18-11/h3-6H,1-2H3,(H,20,21)(H3,16,17,18,19)	BMRWXFQLOMKCPL-UHFFFAOYSA-N	297373	US10112955, Example 43::5-((6-aminopyrimidin-4-yl)amino)-7-chloro-3,3-dimethylisoindolin-1-one (Cpd. No. 43)	MAP kinase-interacting serine/threonine-protein kinase 1	Human		<10							US Patent		10.7270/Q24J0H5T		aid1795977	US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297373	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297373&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129071532	381620229							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569872	CC1(C)NC(=O)c2c1cc(Nc1cc(N)ncn1)cc2Cl	InChI=1S/C14H14ClN5O/c1-14(2)8-3-7(4-9(15)12(8)13(21)20-14)19-11-5-10(16)17-6-18-11/h3-6H,1-2H3,(H,20,21)(H3,16,17,18,19)	BMRWXFQLOMKCPL-UHFFFAOYSA-N	297373	US10112955, Example 43::5-((6-aminopyrimidin-4-yl)amino)-7-chloro-3,3-dimethylisoindolin-1-one (Cpd. No. 43)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297373	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297373&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071532	381620229							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569873	Cc1cc(Nc2cc(N)ncn2)cc2c1C(=O)NC2(C)C	InChI=1S/C15H17N5O/c1-8-4-9(19-12-6-11(16)17-7-18-12)5-10-13(8)14(21)20-15(10,2)3/h4-7H,1-3H3,(H,20,21)(H3,16,17,18,19)	MGKIJMHXDVYGSP-UHFFFAOYSA-N	297374	US10112955, Example 44::5-((6-aminopyrimidin-4-yl)amino)-3,3,7-trimethylisoindolin-1-one (Cpd. No. 44)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297374	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297374&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071630	381620230							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569874	Clc1cc(Nc2ccncn2)cc2c1C(=O)NC21CCCCC1	InChI=1S/C17H17ClN4O/c18-13-9-11(21-14-4-7-19-10-20-14)8-12-15(13)16(23)22-17(12)5-2-1-3-6-17/h4,7-10H,1-3,5-6H2,(H,22,23)(H,19,20,21)	LJMJVDVFEYCHGV-UHFFFAOYSA-N	297375	US10112955, Example 46::4'-chloro-6'-(pyrimidin-4-ylamino)spiro[cyclohexane-1,1&#8242;-isoindolin]-3&#8242;-one (Cpd. No. 46)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297375	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297375&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071526	381620231							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569875	Nc1cc(Nc2cc3c(C(=O)NC33CCCC3)c(Cl)c2)ncn1	InChI=1S/C16H16ClN5O/c17-11-6-9(21-13-7-12(18)19-8-20-13)5-10-14(11)15(23)22-16(10)3-1-2-4-16/h5-8H,1-4H2,(H,22,23)(H3,18,19,20,21)	ZIOFWZKAANPXBF-UHFFFAOYSA-N	297376	US10112955, Example 47::6'-((6-aminopyrimidin-4-yl)amino)-4'-methylspiro[cyclopentane-1,1'-isoindolin]-3'-one (Cpd. No. 47)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297376	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297376&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129087794	381620232							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569876	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)cc2c1C(=O)NC21CCCCC1	InChI=1S/C21H22ClN5O2/c22-15-9-13(8-14-18(15)20(29)27-21(14)6-2-1-3-7-21)25-16-10-17(24-11-23-16)26-19(28)12-4-5-12/h8-12H,1-7H2,(H,27,29)(H2,23,24,25,26,28)	LTBLEBCKEBPQOX-UHFFFAOYSA-N	297377	US10112955, Example 48::6'-((6-aminopyrimidin-4-yl)amino)-4'-chlorospiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 48)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297377	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297377&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071501	381620233							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569877	NC(=O)c1ccc2ncn(-c3cc(N)ncn3)c2c1	InChI=1S/C12H10N6O/c13-10-4-11(16-5-15-10)18-6-17-8-2-1-7(12(14)19)3-9(8)18/h1-6H,(H2,14,19)(H2,13,15,16)	MFVMIWJUHVDUAG-UHFFFAOYSA-N	297378	US10112955, Example 49::1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazole-5-carboxamide (Cpd. No. 49)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297378	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297378&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			137529650	381620234							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569878	CC1(C)NC(=O)c2c1cc(Nc1ncnc(N)c1Cl)cc2Cl	InChI=1S/C14H13Cl2N5O/c1-14(2)7-3-6(4-8(15)9(7)13(22)21-14)20-12-10(16)11(17)18-5-19-12/h3-5H,1-2H3,(H,21,22)(H3,17,18,19,20)	WVJMPLJFIANISJ-UHFFFAOYSA-N	297379	US10112955, Example 50::5-((6-amino-5-chloropyrimidin-4-yl)amino)-7-chloro-3,3-dimethylisoindolin-1-one (Cpd. No. 50)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297379	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297379&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071377	381620235							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569879	Cc1cc(Nc2cc(N)ncn2)cc2c1C(=O)NC21CCCCC1	InChI=1S/C18H21N5O/c1-11-7-12(22-15-9-14(19)20-10-21-15)8-13-16(11)17(24)23-18(13)5-3-2-4-6-18/h7-10H,2-6H2,1H3,(H,23,24)(H3,19,20,21,22)	SQGMWDPPMPYMEA-UHFFFAOYSA-N	297380	US10112955, Example 51::6'-((6-aminopyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'isoindolin]-3'-one (Cpd. No. 51)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297380	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297380&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071637	381620236							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569880	CC1(C)NC(=O)c2ccc(Nc3cc(N)ncn3)c(Cl)c12	InChI=1S/C14H14ClN5O/c1-14(2)11-7(13(21)20-14)3-4-8(12(11)15)19-10-5-9(16)17-6-18-10/h3-6H,1-2H3,(H,20,21)(H3,16,17,18,19)	VAKKMMCAZDOPFK-UHFFFAOYSA-N	297381	US10112955, Example 52::5-((6-aminopyrimidin-4-yl)amino)-4-chloro-3,3-dimethylisoindolin-1-one (Cpd. No. 52)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297381	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297381&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071380	381620237							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569881	CCc1c(N)ncnc1Nc1cc2c(C(=O)NC22CCCCC2)c(C)c1	InChI=1S/C20H25N5O/c1-3-14-17(21)22-11-23-18(14)24-13-9-12(2)16-15(10-13)20(25-19(16)26)7-5-4-6-8-20/h9-11H,3-8H2,1-2H3,(H,25,26)(H3,21,22,23,24)	OVNBDNRTAYKQCW-UHFFFAOYSA-N	297382	US10112955, Example 53::6'-((6-amino-5-ethylpyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 53)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297382	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297382&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071653	381620238							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569882	COc1cncnc1Nc1cc2c(C(=O)NC22CCCCC2)c(C)c1	InChI=1S/C19H22N4O2/c1-12-8-13(22-17-15(25-2)10-20-11-21-17)9-14-16(12)18(24)23-19(14)6-4-3-5-7-19/h8-11H,3-7H2,1-2H3,(H,23,24)(H,20,21,22)	LNNKYMWLAJWJHG-UHFFFAOYSA-N	297383	US10112955, Example 54::6'-((5-methoxypyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 54)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297383	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297383&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071421	381620239							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569883	Cc1cc(Nc2ncnc(N)c2C)cc2c1C(=O)NC21CCCCC1	InChI=1S/C19H23N5O/c1-11-8-13(23-17-12(2)16(20)21-10-22-17)9-14-15(11)18(25)24-19(14)6-4-3-5-7-19/h8-10H,3-7H2,1-2H3,(H,24,25)(H3,20,21,22,23)	QDPCTFOPIVWFRH-UHFFFAOYSA-N	297384	US10112955, Example 55::6'-((6-amino-5-methylpyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 55)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297384	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297384&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122634960	381620240							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569884	CCc1cncnc1Nc1cc2c(C(=O)NC22CCCCC2)c(C)c1	InChI=1S/C20H24N4O/c1-3-14-11-21-12-22-18(14)23-15-9-13(2)17-16(10-15)20(24-19(17)25)7-5-4-6-8-20/h9-12H,3-8H2,1-2H3,(H,24,25)(H,21,22,23)	ZMSUEFOQSHBEBD-UHFFFAOYSA-N	297385	US10112955, Example 56::6'-((5-ethylpyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 56)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		 550							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297385	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297385&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071608	381620241							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569885	COc1c(N)ncnc1Nc1cc2c(C(=O)NC22CCCCC2)c(C)c1	InChI=1S/C19H23N5O2/c1-11-8-12(23-17-15(26-2)16(20)21-10-22-17)9-13-14(11)18(25)24-19(13)6-4-3-5-7-19/h8-10H,3-7H2,1-2H3,(H,24,25)(H3,20,21,22,23)	XKDQHXCKDQNWAW-UHFFFAOYSA-N	297386	US10112955, Example 57::6'-((6-amino-5-methoxypyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 57)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297386	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297386&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071373	381620242							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569886	Cc1cc(Nc2ncnc(N)c2Cl)cc2c1C(=O)NC21CCCCC1	InChI=1S/C18H20ClN5O/c1-10-7-11(23-16-14(19)15(20)21-9-22-16)8-12-13(10)17(25)24-18(12)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,24,25)(H3,20,21,22,23)	FIOYHBCPYRHWNY-UHFFFAOYSA-N	297387	US10112955, Example 58::6'-((6-amino-5-chloropyrimidin-4-yl)amino)-4'-methylspiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 58)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297387	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297387&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122634961	381620243							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
569887	Nc1ncnc(Nc2cc3c(C(=O)NC33CCCCC3)c(Cl)c2)c1Cl	InChI=1S/C17H17Cl2N5O/c18-11-7-9(23-15-13(19)14(20)21-8-22-15)6-10-12(11)16(25)24-17(10)4-2-1-3-5-17/h6-8H,1-5H2,(H,24,25)(H3,20,21,22,23)	YQNGQUQVWJGVJE-UHFFFAOYSA-N	297388	US10112955, Example 59::6'-((6-amino-5-chloropyrimidin-4-yl)amino)-4'-chlorospiro[cyclohexane-1,1'-isoindolin]-3'-one (Cpd. No. 59)	MAP kinase-interacting serine/threonine-protein kinase 2	Human		<10							US Patent		10.7270/Q24J0H5T			US10112955	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE; Shaghafi, M; Murphy, D; Tran, C	10/30/2018	3/11/2019	Effector Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=297388	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=297388&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129071602	381620244							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6